In the present study, IL20RB was identified as an independent prognostic factor for ccRCC; in addition, the IL20 subfamily, including IL19, IL20, and IL24, is involved in both amplified inflammatory responses and anti-inflammatory responses, such as tissue protection and regeneration [30–33]. Here, IL19 is linked to nonpapillary renal cell carcinoma.